BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Evaxion Biotech

Evaxion Biotech logo

Website
http://evaxion-biotech.com/
Founded
2008
Patents
33
Clinical Trials
2
Publications
25

Technologies

AI Companies (Drug Discovery)

Using cutting-edge immunology, bioinformatics, and machine learning methods, Evaxion Biotech is discovering and developing 'best in class’ vaccines for infectious diseases and cancer at an unprecedented rate. We have constructed a robust product engine for the development of novel vaccines and therapies based on our two platforms, PIONEER and EDEN. Using state of the art in silico tools, the platforms integrate big data, artificial intelligence and supercomputing to predict, rank and optimize epitopes and antigens that elicit a highly protective immune response against cancers and infectious diseases. EDEN enables rapid and accurate discovery of novel antigens that elicit a highly cross-protective immune response in any bacterial pathogen while PIONEER has been constructed to identify the epitopes of mutated proteins that will fire up the body’s natural immune responses to them.

Immunoinformatics Immunotherapy Antigen Discovery Bioinformatics


Posts Mentioning This Company

10 Companies Applying AI for Biologics Discovery

Jan. 26, 2024  
When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery in the first place. Indeed, as it was captured and analyzed in the report The Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D roughly half of more than 300 analyzed …
These 5 Companies Enable Precision Oncology Using AI

Six AI-driven Drug Discovery Companies Enabling Precision Oncology

June 29, 2023  
Artificial Intelligence (AI) is steadily making its presence felt across various sectors, including the pharmaceutical industry. Among the multiple applications of AI in this field, immunotherapy - a treatment method that utilizes the body's immune system to combat diseases, notably cancer - is seeing a significant influence. The integration of …

A Parade of AI-driven Biotechs Going Public in 2020-2021

Sept. 24, 2021  
Over 2020-2021 we have seen a remarkable parade of artificial intelligence (AI), focused on discovering novel therapeutics, going public. This reflects a continuing interest in AI as a transformative technology for the pharmaceutical industry and increasing belief in the wave of technology-driven “neo-biotechs”. Here we list some notable companies which …

Pharmaceutical AI in 2021: Key Developments So Far

Aug. 9, 2021  
Table of Contents:   Introduction Artificial intelligence (AI) in drug discovery yields breakthroughs The abundance of venture capital, major funding rounds IPOs of AI Pharma Companies in 2021 New AI-driven biotech startups founded in 2020 Notable AI-focused collaborations involving “big pharma” players AI adoption by the contract research organizations (CROs)  …
Danish Biotech Uses AI To Develop Anticancer And Antimicrobial Vaccines

Evaxion Biotech Uses AI To Develop Anticancer And Antimicrobial Vaccines

Aug. 21, 2017  
This is an interview with Niels Iversen Møller, a CEO, and Co-founder of Evaxion Biotech -- an immuno-informatics biotech from Denmark. Evaxion Biotech uses its machine learning-based platform to compare DNAs of tumor cells and DNAs healthy cells and identify mutations that are critical for the disease. This data is …
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

We are an AI-immunology platform company using our proprietary artificial intelligence technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop unique immunotherapies for patients.

News

  • 2024-12-13
    Evaxion Biotech Announces Proof-of-Concept for AI-Driven Cancer Vaccines Targeting Endogenous Retrovirus Tumor Antigens
  • 2024-07-16
    Evaxion Biotech Showcases Enhanced AI-Immunology™ Capabilities at ISMB 2024

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.